Diniz-Freitas M, López-Cedrún
JL, Fernández-Sanromán J, García-García
A, Fernández-Feijoo J, Diz-Dios
P. Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a
series of 20 cases in Spain. Med Oral Patol
Oral Cir Bucal. 2012 Sep 1;17
(5):e751-8.
doi:10.4317/medoral.18041
1. Lin JT,
Lane JM. Osteoporosis: a review. Clin Orthop Relat Res. 2004;425:126-34.
http://dx.doi.org/10.1097/01.blo.0000132404.30139.f2
PMid:15292797
2. Erviti
J. Drug prescription for osteoporosis. An Sist Sanit Navar.
2003;26:107-21.
PMid:14716363
3. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367:2010-8.
http://dx.doi.org/10.1016/S0140-6736(06)68891-0
4. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis
of the Jaws, American Association of Oral and Maxillofacial Surgeons.
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis
of the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580
5. Barasch A, Cunha-Cruz J,
Curro FA, Hujoel P, Sung
AH, Vena D, et al. Risk factors for osteonecrosis
of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res. 2011;90:439-44.
http://dx.doi.org/10.1177/0022034510397196
PMid:21317246 PMCid:3144129
6. Otto S, Abu-Id MH, Fedele S, Warnke
PH, Becker ST, Kolk A, et al. Osteoporosis and bisphosphonates-related osteonecrosis
of the jaw: Not just a sporadic coincidence - a multi-centre study. J Craniomaxillofac Surg. 2011;39:272-7.
http://dx.doi.org/10.1016/j.jcms.2010.05.009
PMid:20580566
7. Ruggiero SL, Dodson
TB, Assael LA, Landesberg
R, Marx RE, Mehrotra B et al. American
Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis
of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.
http://dx.doi.org/10.1016/j.joms.2009.01.009
PMid:19371809
8. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis
of the jaws: a growing epidemic. J Oral Maxillofac
Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1
9. Mavrokokki T, Cheng A,
Stein B, Goss A. Nature and frequency of bisphosphonate-associated
osteonecrosis of the jaws in Australia. J Oral Maxillofac
Surg. 2007;65:415-23.
http://dx.doi.org/10.1016/j.joms.2006.10.061
PMid:17307586
10. Marx RE, Cillo JE Jr,
Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum
CTX testing, prevention, and treatment. J Oral Maxillofac
Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003
PMid:18022461
11. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Bisphosphonate-related
osteonecrosis of the jaws: a case series of 25
patients affected by osteoporosis. Int J Oral Maxillofac Surg. 2011;40:277-84.
http://dx.doi.org/10.1016/j.ijom.2010.11.002
PMid:21163625
12. Hong JW, Nam W, Cha IH, Chung SW, Choi HS, Kim
KM, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int. 2010;21:847-53.
http://dx.doi.org/10.1007/s00198-009-1024-9
PMid:19633881
13. Favia G, Pilolli GV, Maiorano E. Osteonecrosis of the
jaw correlated to bisphosphonate therapy in
Non-oncologic patients: Clinicopathologicl features
of 24 patients. J Rheumatol.
2009;26:2780-7.
http://dx.doi.org/10.3899/jrheum.090455
PMid:19884275
14. Lo JC, O’Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, et al. Prevalence of osteonecrosis
of the jaw in patients with oral bisphosphonate
exposure. J Oral Maxillofac Surg. 2010;68:243-53.
http://dx.doi.org/10.1016/j.joms.2009.03.050
PMid:19772941
15. Kwon YD, Kim DY, Ohe JY, Yoo
JY, Walter C. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis
of the jaws. J Oral Maxillofac Surg. 2009;67:2644-8.
http://dx.doi.org/10.1016/j.joms.2009.04.067
PMid:19925985
16. Williamson RA. Surgical management of bisphosphonate
induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010;39:251-5.
http://dx.doi.org/10.1016/j.ijom.2009.11.014
PMid:20015614
17. Lazarovici TS, Yahalom
R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis
of the jaws: a single-center study of 101 patients. J Oral Maxillofac
Surg. 2009;67:850-5.
http://dx.doi.org/10.1016/j.joms.2008.11.015
PMid:19304045
18. Barrier A, Lescaille G, Rigolet
A, Descroix V, Goudot P, Ruhin B. Jaw osteonecrosis
induced by oral bisphosphonates: 12 cases. Rev Stomatol Chir Maxillofac.
2010;111:196-202.
http://dx.doi.org/10.1016/j.stomax.2010.07.009
PMid:20810140
19. Chiu CT, Chiang WF, Chuang CY, Chang SW. Resolution of oral bisphosphonate andsteroid-related
osteonecrosis of the jaw--a serial case analysis. J
Oral Maxillofac Surg. 2010;68:1055-63.
http://dx.doi.org/10.1016/j.joms.2009.12.030
PMid:20403529
20. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing
factors and treatment outcome. Osteoporos Int. 2007;18:1363-70.
http://dx.doi.org/10.1007/s00198-007-0384-2
PMid:17598065
21. Hutchinson M, O’Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, et al. Radiographic
findings in bisphosphonate-treated patients with
stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg. 2010;68:2232-40.
http://dx.doi.org/10.1016/j.joms.2010.05.003
PMid:20728032
22. Bagán JV, Murillo J, Jiménez Y, Poveda R, Milián MA, Sanchís JM, et al. Avascular
jaw osteonecrosis in association with cancer
chemotherapy: series of 10 cases. J Oral Pathol Med.
2005;34:120-3.
http://dx.doi.org/10.1111/j.1600-0714.2004.00269.x
PMid:15641993
23. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA, et al. Updated Recommendations for Managing
the Care of Patients Receiving Oral Bisphosphonate
Therapy: An Advisory Statement From the American Dental Association Council on
Scientific Affairs. JADA. 2008;139:1674-7.
PMid:19047674
24. Palaska PK, Cartsos V, Zavras
AI. Bisphosphonates and time to osteonecrosis development.
Oncologist. 2009;14:1154-66.
http://dx.doi.org/10.1634/theoncologist.2009-0115
PMid:19897878
25. Grana J, Mahia IV, Meizoso MO, Vazquez T. Multiple osteonecrosis
of the jaw, oral bisphosphonate therapy and
refractory rheumatoid arthritis (Pathological fracture associated with ONJ and
BP use for osteoporosis). Clin Exp Rheumatol. 2008;26:384-5.
PMid:18565271
26. Tankó LB, Christiansen C, Cox DA, Geiger MJ,
McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular
disease in postmenopausal women. J Bone Miner Res. 2005;20:1912-20.
http://dx.doi.org/10.1359/JBMR.050711
PMid:16234963
27. Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, et al. Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol
Metab. 2007;92:1172-5.
http://dx.doi.org/10.1210/jc.2006-2036
28. Valdés S, Rojo-Martínez G, Soriguer
F. [Evolution of prevalence of type 2 diabetes in adult Spanish population].
Med Clin (Barc).
2007;129:352-5.
http://dx.doi.org/10.1157/13109554
29. de Paula FJ, Horowitz MC,
Rosen CJ. Novel insights into the relationship between diabetes
and osteoporosis. Diabetes
Metab Res Rev. 2010;26:622-30.
http://dx.doi.org/10.1002/dmrr.1135
PMid:20938995 PMCid:3259009
30. Neto NC, de Souza Bastos A, Chierici-Marcantonio
RA, Marcantonio E Jr. Is rheumatoid
arthritis a risk factor for oral bisphosphonate-induced
osteonecrosis of the jaws?. Med Hypotheses. 2011;77:905-11.
http://dx.doi.org/10.1016/j.mehy.2011.08.008
PMid:21885199
31. Sonis ST, Watkins BA, Lyng
GD, Lerman MA, Anderson KC. Bony changes in the jaws
of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis
in cancer patients. Oral Oncol.
2009;45:164-72.
http://dx.doi.org/10.1016/j.oraloncology.2008.04.013
PMid:18715819
32. Hikita H, Miyazawa K, Tabuchi
M, Kimura M, Goto S. Bisphosphonate
administration prior to tooth extraction delays initial healing of the
extraction socket in rats. J Bone Miner Metab.
2009;27:663-72.
http://dx.doi.org/10.1007/s00774-009-0090-6
PMid:19436946
33. Kim RH, Lee RS, Williams D, Bae S, Woo J,
Lieberman M, et al. Bisphosphonates induce senescence
in normal human oral keratinocytes. J Dent Res. 2011;90:810-6.
http://dx.doi.org/10.1177/0022034511402995
PMid:21427353 PMCid:3144120
34. Kyrgidis A, Vahtsevanos
K. Increased risk for bisphosphonate-related osteonecrosis of the jaws in patients wearing dentures
could be attributable to impaired mucosal cell wound healing. J Oral Maxillofac Surg. 2009;67:1355-6.
http://dx.doi.org/10.1016/j.joms.2008.05.368
PMid:19446234
35. Kunchur R, Goss AN. The oral
health status of patients on oral bisphosphonates for
osteoporosis. Aust Dent J.2008;53:354-7.
http://dx.doi.org/10.1111/j.1834-7819.2008.00078.x
PMid:19133952